Related Experiment Video
Updated: Jun 19, 2026

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
Reversible cell cycle arrest with concomitant p21/WAF1 overexpression and mitochondrial destruction by nitric oxide
1Investigative Treatment Division, National Cancer Center Research Institute, Chiba, Japan.
Abstract:
When human hepatocellular carcinoma Hep-G2 cells were treated with the NO-generating compounds, S-nitroso-N-acetyl-DL-penicillamine(SNAP) or (+/-)-(E)-4-ethyl-2-(E)-hydroxyimino]-5-nitroso-3-hexenamide, cells stopped growing. Most cells were found to be in either G1 or G2/M phase and the dye-exclusion test revealed that the cells were alive. Electron microscopic examination confirmed the integrity of cells and nuclei. Nuclear staining with the DNA-binding dye H33258 revealed that cells did not undergo apoptosis although dramatic changes in mitochondrial morphology were noticed within 6 hr of treatment with SNAP by electron microscopy. Western and northern blot analysesrevealed that cells overexpressed p21/WAF1. The growth arrest was released by withdrawal of the NO-generating compound and cells started to divide within 24 hr after withdrawal of the compounds.
Insights
Nitric oxide (NO) generating compounds halt hepatocellular carcinoma cell growth by arresting cells in G1 or G2/M phases. This reversible growth arrest, linked to p21/WAF1 overexpression, does not induce apoptosis.
Area of Science:
- Hepatocellular carcinoma research
- Cell cycle regulation
- Nitric oxide signaling
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- Nitric oxide (NO) plays complex roles in cancer, including potential anti-tumor effects.
- Understanding NO's impact on HCC cell cycle progression is crucial for therapeutic development.
Purpose of the Study:
- To investigate the effects of NO-generating compounds on human hepatocellular carcinoma HepG2 cell growth.
- To determine the cell cycle phase distribution and viability of NO-treated HepG2 cells.
- To elucidate the molecular mechanisms underlying NO-induced growth arrest in HCC.
Main Methods:
- Treatment of HepG2 cells with NO-generating compounds (SNAP, etc.).
- Cell cycle analysis using flow cytometry and dye exclusion tests.
- Electron microscopy for cellular and mitochondrial morphology assessment.
- Western and Northern blot analyses for p21/WAF1 expression.
Main Results:
- NO-generating compounds induced a reversible growth arrest in HepG2 cells.
- Treated cells accumulated in G1 and G2/M phases, maintaining viability.
- Significant mitochondrial morphological changes were observed without apoptosis induction.
- Overexpression of p21/WAF1 was detected in NO-treated cells.
Conclusions:
- NO-generating compounds effectively inhibit HCC cell proliferation.
- The observed growth arrest is mediated by cell cycle regulation, specifically p21/WAF1.
- NO-induced effects on HepG2 cells are reversible and do not trigger programmed cell death.
More Related Videos
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...